查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612747

犬異位性皮膚炎市場：按產品、過敏原、給藥途徑、分銷管道和最終用戶 - 2025-2030 年全球預測

Canine Atopic Dermatitis Market by Product (Antihistamines, Glucocorticoids, Immunosuppressants), Allergen (Dander, Microorganisms, Mites), Route of Administration, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年犬異位性皮膚炎市值為15.7億美元，預計到2024年將達到16.9億美元，複合年成長率為8.40%，到2030年將達到27.6億美元。

犬異位性皮膚炎（CAD）是犬類常見的過敏性疾病，其特徵是過敏原引起的皮膚發炎。寵物擁有量的增加和寵物健康意識的提高凸顯了對有效 CAD 治療的需求，從而推動了對創新治療的需求。 CAD 治療的應用範圍從提供專業皮膚科服務的獸醫診所到含有抗組織胺藥物和免疫抑制劑的家庭護理產品。最終用途範圍主要包括寵物飼主和獸醫專業人士尋求增強的治療方案以改善寵物的福利並減輕症狀。市場成長主要是由生物技術和製藥的進步、研發投資的增加以及提供更有效且副作用更少的標靶治療的新產品的推出所推動的。此外，寵物過敏的盛行率不斷上升，以及寵物飼主將寵物視為家庭成員的人性化，正在為高成本治療解決方案創造機會。然而，挑戰包括嚴格的監管核准、長期用藥的潛在副作用以及創新治療方法的高成本。其他障礙包括寵物對治療的不同反應以及需要更好地了解 CAD 的遺傳和環境觸發因素。主要市場開拓包括開發新型生技藥品、根據個別寵物的需求量身定做治療的個人化醫療方法，以及能夠早期準確識別 CAD 的創新診斷工具。創新領域專注於整合資料分析和人工智慧驅動的平台，以預測過敏模式並客製化預防措施。隨著公司努力滿足未滿足的消費者需求並擴大 CAD 的治療選擇，市場正在向非侵入性治療、營養食品和益生菌解決方案轉變，這表明它具有廣闊的未來性。對於尋求在競爭環境中實現成長和廣泛採用的公司來說，平衡有效性和可負擔性至關重要。

主要市場統計
基準年[2023] 15.7億美元
預測年份 [2024] 16.9億美元
預測年份 [2030] 27.6億美元
複合年成長率（%） 8.40%

市場動態：快速發展的犬異位性皮膚炎市場的關鍵市場洞察

供需的動態交互作用正在改變犬特應性皮膚炎市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 寵物數量增加，狗過敏原污染增加
    • 越來越關注天然成分或非藥物方法
  • 市場限制因素
    • 寵物仿單標示外用藥增加
  • 市場機會
    • 由於犬異位性皮膚炎 (CAD) 的研發投資，產品推出量增加
    • 對寵物保險的持續需求和飼主日益成長的興趣
  • 市場挑戰
    • 對 CAD 複雜病因及其治療效果和安全性的擔憂

波特的五力：駕馭犬異位性皮膚炎市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對犬異位性皮膚炎市場的影響

外部宏觀環境因素在塑造犬異位性皮膚炎市場的表現動態中發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析了解犬異位性皮膚炎市場的競爭狀況

犬異位性皮膚炎市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣供應商在犬異位性皮膚炎市場的績效評估

FPNV定位矩陣是評估犬異位性皮膚炎市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製犬異位性皮膚炎市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對犬特應性皮膚炎市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 寵物數量增加以及與狗過敏原相關的污染增加
      • 更重視天然成分和非藥物方法
    • 抑制因素
      • 寵物使用仿單標示外藥物的情況增加
    • 機會
      • 增加犬異位性皮膚炎（CAD）產品的研發投資
      • 對寵物保險的持續需求和寵物主人日益成長的擔憂
    • 任務
      • 對 CAD 複雜病因以及治療有效性和安全性的擔憂
  • 市場區隔分析
    • 產品：擴大抗組織胺和糖皮質激素的使用，有效治療 CAD
    • 過敏原：塵蟎和微小寄生蟲是 CAD 的主要原因
    • 給藥途徑：注射和口服是最優選的給藥方法。
    • 分銷管道：透過線上分銷管道提高 CAD 藥物的供應
    • 最終使用者：CAD 診斷的增加和對臨床有效治療的需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章犬異位性皮膚炎市場：依產品

  • 抗組織胺藥
  • 糖皮質激素
  • 免疫抑制劑
  • 單株抗體

第7章犬異位性皮膚炎市場過敏原

  • 頭皮
  • 微生物
  • 打鉤
  • 花粉

第8章犬異位性皮膚炎市場：依給藥途徑

  • 可注射的
  • 口服
  • 話題

第9章犬異位性皮膚炎市場：按分銷管道

  • 醫院/診所
  • 線上
  • 零售獸醫

第 10 章犬異位性皮膚炎市場：依最終用戶分類

  • 醫院
  • 獸醫診所

第11章 北美和南美犬異位性皮膚炎市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區犬異位性皮膚炎市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲犬異位性皮膚炎市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 碩騰在美國內布拉斯加州林肯市開設最先進的工廠
    • Zoetis 宣布 FDA核准Apoquel 咀嚼片（Oclacitinib 咀嚼片）用於抑制與過敏性皮膚炎和異位性皮膚炎相關的犬癢症
    • ILC Therapeutics 與 Decla Pharmaceuticals 建立策略研發合作夥伴關係
    • Bioiberica 使用基於脂質的生物圈成分推出用於治療異位性皮膚炎的狗和貓項圈
    • 皇家犬北美公司宣布推出 SKINTOPIC 來幫助治療犬異位性皮膚炎
  • 戰略分析和建議

公司名單

  • AB Science SA
  • AbbVie, Inc.
  • Agrolabo SpA
  • Bimeda, Inc.
  • Bioceltix JSC
  • Bioiberica SAU
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Deep Marine Collagen
  • Elanco Animal Health Incorporated
  • Farnam Companies, Inc.
  • IDEXX Laboratories, Inc.
  • Incyte Corporation
  • Kemin Industries, Inc.
  • LEO Pharma A/S
  • Merck & Co. Inc.
  • Natural Dog Company
  • Nextmune
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Novartis AG
  • Ourofino Animal Health
  • Pfizer Inc
  • Phibro Animal Health Corporation
  • Regeneron Pharmaceuticals, Inc
  • Saiba Animal Health AG
  • Toray Industries Inc.
  • Vetoquinol SA
  • Virbac Corporation
  • Zinpro Corporation
  • Zoetis Inc.
  • Zymox by Pet King Brands LLC
Product Code: MRR-A339DAEFA20E

The Canine Atopic Dermatitis Market was valued at USD 1.57 billion in 2023, expected to reach USD 1.69 billion in 2024, and is projected to grow at a CAGR of 8.40%, to USD 2.76 billion by 2030.

Canine Atopic Dermatitis (CAD) is a prevalent allergic condition in dogs characterized by inflammation of the skin due to allergens. The necessity for effective CAD treatment is underscored by the growing pet ownership and heightened awareness about pet health, which pushes demand for innovative therapies. The application of CAD treatments spans from veterinary clinics offering specialized dermatological services to home-care products incorporating antihistamines and immunosuppressant formulations. The end-use scope primarily involves pet owners and veterinary professionals seeking enhanced treatment options to improve pet welfare and alleviate symptoms. Market growth is significantly driven by the advancement of biotech and pharmaceutical products, increased R&D investments, and new product launches that offer more effective, targeted therapies with fewer side effects. Additionally, the rising prevalence of pet allergies and the humanization of pets-where pet owners increasingly treat pets as part of the family-create opportunities for premium-priced therapeutic solutions. However, limitations such as stringent regulatory approvals, potential side effects of long-term medication use, and the high cost of innovative treatments present challenges. Additional hurdles include the variability in pet response to treatment and a need for greater understanding of CAD's genetic and environmental triggers. Key potential opportunities in the market exist in developing novel biologics, personalized medicine approaches that tailor treatments to individual pet needs, and revolutionary diagnostic tools that enable early and accurate identification of CAD. Innovation areas focus on integrating data analytics and AI-driven platforms to predict allergy patterns and customize preventive measures. The market is dynamic, with a shift towards non-invasive treatments, nutraceuticals, and probiotic solutions, suggesting a future rich with potential as companies strive to address unmet consumer needs and expand the therapeutic arsenal against CAD. Balancing efficacy and affordability will be crucial for companies looking to capture growth and ensure broad adoption in a competitive landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.57 billion
Estimated Year [2024] USD 1.69 billion
Forecast Year [2030] USD 2.76 billion
CAGR (%) 8.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Canine Atopic Dermatitis Market

The Canine Atopic Dermatitis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of pet ownership and rising pollution related to allergens on dogs
    • Rising focus on natural ingredients or non-pharmacological methods
  • Market Restraints
    • Increasing use of off-label drugs among pets
  • Market Opportunities
    • Rise in the R&D investments product launches for canine atopic dermatitis (CAD)
    • Ongoing demand for pet insurance and rising concerns among pet owners
  • Market Challenges
    • Complex etiology of CAD & concerns over treatment efficacy and safety

Porter's Five Forces: A Strategic Tool for Navigating the Canine Atopic Dermatitis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Canine Atopic Dermatitis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Canine Atopic Dermatitis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Canine Atopic Dermatitis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Canine Atopic Dermatitis Market

A detailed market share analysis in the Canine Atopic Dermatitis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Canine Atopic Dermatitis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Canine Atopic Dermatitis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Canine Atopic Dermatitis Market

A strategic analysis of the Canine Atopic Dermatitis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canine Atopic Dermatitis Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, AbbVie, Inc., Agrolabo SpA, Bimeda, Inc., Bioceltix JSC, Bioiberica S.A.U., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Deep Marine Collagen, Elanco Animal Health Incorporated, Farnam Companies, Inc., IDEXX Laboratories, Inc., Incyte Corporation, Kemin Industries, Inc., LEO Pharma A/S, Merck & Co. Inc., Natural Dog Company, Nextmune, Nippon Zenyaku Kogyo Co., Ltd., Novartis AG, Ourofino Animal Health, Pfizer Inc, Phibro Animal Health Corporation, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Toray Industries Inc., Vetoquinol S.A., Virbac Corporation, Zinpro Corporation, Zoetis Inc., and Zymox by Pet King Brands LLC.

Market Segmentation & Coverage

This research report categorizes the Canine Atopic Dermatitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antihistamines, Glucocorticoids, Immunosuppressants, and Monoclonal Antibodies.
  • Based on Allergen, market is studied across Dander, Microorganisms, Mites, and Pollen.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Distribution Channel, market is studied across Hospitals & Clinics, Online, and Retail Veterinary.
  • Based on End-User, market is studied across Hospitals and Veternary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of pet ownership and rising pollution related to allergens on dogs
      • 5.1.1.2. Rising focus on natural ingredients or non-pharmacological methods
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing use of off-label drugs among pets
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the R&D investments product launches for canine atopic dermatitis (CAD)
      • 5.1.3.2. Ongoing demand for pet insurance and rising concerns among pet owners
    • 5.1.4. Challenges
      • 5.1.4.1. Complex etiology of CAD & concerns over treatment efficacy and safety
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding use of antihistamines and glucocorticoids for effective treatment of CAD
    • 5.2.2. Allergen: Dust mites and microscopic parasites prevail as the major cause of CAD
    • 5.2.3. Route of Administration: Injectables and orals to be the most preferred mode of medication application
    • 5.2.4. Distribution Channel: Emerging availability of CAD medications through online distribution channels
    • 5.2.5. End-User: Increasing CAD diagnosis in clinics and need for effective treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Canine Atopic Dermatitis Market, by Product

  • 6.1. Introduction
  • 6.2. Antihistamines
  • 6.3. Glucocorticoids
  • 6.4. Immunosuppressants
  • 6.5. Monoclonal Antibodies

7. Canine Atopic Dermatitis Market, by Allergen

  • 7.1. Introduction
  • 7.2. Dander
  • 7.3. Microorganisms
  • 7.4. Mites
  • 7.5. Pollen

8. Canine Atopic Dermatitis Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Canine Atopic Dermatitis Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Online
  • 9.4. Retail Veterinary

10. Canine Atopic Dermatitis Market, by End-User

  • 10.1. Introduction
  • 10.2. Hospitals
  • 10.3. Veternary Clinics

11. Americas Canine Atopic Dermatitis Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Canine Atopic Dermatitis Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Canine Atopic Dermatitis Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Zoetis Opens New State-of-the-Art Facility in Lincoln, NE, USA
    • 14.3.2. Zoetis Announces FDA Approval of Apoquel Chewable (oclacitinib chewable tablet) for Control of Pruritus Associated With Allergic Dermatitis and Control of Atopic Dermatitis in Dogs
    • 14.3.3. ILC Therapeutics entered into a strategic R&D partnership with Dechra Pharmaceuticals
    • 14.3.4. Bioiberica Launches Dog And Cat Collar For Atopic Dermatitis Featuring Company's Lipids-Based Biosfeen Ingredient
    • 14.3.5. Royal Canin North America Announces Launch of SKINTOPIC to Help in the Management of Canine Atopic Dermatitis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AB Science SA
  • 2. AbbVie, Inc.
  • 3. Agrolabo SpA
  • 4. Bimeda, Inc.
  • 5. Bioceltix JSC
  • 6. Bioiberica S.A.U.
  • 7. Boehringer Ingelheim International GmbH
  • 8. Ceva Sante Animale
  • 9. Dechra Pharmaceuticals PLC
  • 10. Deep Marine Collagen
  • 11. Elanco Animal Health Incorporated
  • 12. Farnam Companies, Inc.
  • 13. IDEXX Laboratories, Inc.
  • 14. Incyte Corporation
  • 15. Kemin Industries, Inc.
  • 16. LEO Pharma A/S
  • 17. Merck & Co. Inc.
  • 18. Natural Dog Company
  • 19. Nextmune
  • 20. Nippon Zenyaku Kogyo Co., Ltd.
  • 21. Novartis AG
  • 22. Ourofino Animal Health
  • 23. Pfizer Inc
  • 24. Phibro Animal Health Corporation
  • 25. Regeneron Pharmaceuticals, Inc
  • 26. Saiba Animal Health AG
  • 27. Toray Industries Inc.
  • 28. Vetoquinol S.A.
  • 29. Virbac Corporation
  • 30. Zinpro Corporation
  • 31. Zoetis Inc.
  • 32. Zymox by Pet King Brands LLC

LIST OF FIGURES

  • FIGURE 1. CANINE ATOPIC DERMATITIS MARKET RESEARCH PROCESS
  • FIGURE 2. CANINE ATOPIC DERMATITIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANINE ATOPIC DERMATITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANINE ATOPIC DERMATITIS MARKET DYNAMICS
  • TABLE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DANDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY POLLEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY RETAIL VETERINARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023